| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7727 |
| Human Intestinal Absorption | HIA- | 0.8854 |
| Caco-2 Permeability | Caco2- | 0.8478 |
| P-glycoprotein Substrate | Non-substrate | 0.5946 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7601 |
| Non-inhibitor | 0.9392 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8108 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7518 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8797 |
| CYP450 2D6 Substrate | Non-substrate | 0.8503 |
| CYP450 3A4 Substrate | Non-substrate | 0.6407 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9306 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9287 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9235 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8404 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9307 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8959 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9522 |
| Non-inhibitor | 0.8949 |
| AMES Toxicity | Non AMES toxic | 0.8864 |
| Carcinogens | Non-carcinogens | 0.9529 |
| Fish Toxicity | High FHMT | 0.7679 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8296 |
| Honey Bee Toxicity | High HBT | 0.7650 |
| Biodegradation | Not ready biodegradable | 0.8749 |
| Acute Oral Toxicity | III | 0.4497 |
| Carcinogenicity (Three-class) | Non-required | 0.6934 |